Exosome-Delivered EGFR Induced by Acidic Bile Salts Regulates Macrophage M2 Polarization to Promote Esophageal Adenocarcinoma Cell Proliferation

References

• Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021.
   PubMed Web of Science ®Google Scholar
• Mejza M, Malecka-Wojciesko E. Diagnosis and management of barrett’s esophagus. J Clin Med. 2023;12(6):2141. doi:10.3390/jcm12062141
   PubMed Web of Science ®Google Scholar
• Chen L, Lu H, Peng D, et al. Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-kappaB activation in oesophageal adenocarcinoma. Gut. 2023;72(3):421–432. doi:10.1136/gutjnl-2022-327076
   PubMed Web of Science ®Google Scholar
• Storz L, Walther P, Chemnitzer O, et al. Nrf2/Keap1-pathway activation and reduced susceptibility to chemotherapy treatment by acidification in esophageal adenocarcinoma cells. Cancers. 2021;13(11):2806. doi:10.3390/cancers13112806
   PubMed Web of Science ®Google Scholar
• Liu J, Liu L, Su Y, et al. IL-33 participates in the development of esophageal adenocarcinoma. Pathol Oncol Res. 2022;28:1610474. doi:10.3389/pore.2022.1610474
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem Toxicol. 2022;164:113008. doi:10.1016/j.fct.2022.113008
   PubMed Web of Science ®Google Scholar
• Huang TY, Wang CY, Chen KY, Huang LT. Urinary exosomal thyroglobulin in thyroid cancer patients with post-ablative therapy: a new biomarker in thyroid cancer. Front Endocrinol. 2020;11:382. doi:10.3389/fendo.2020.00382
   PubMed Web of Science ®Google Scholar
• Bano R, Soleja N, Mohsin M. Genetically encoded FRET-based nanosensor for real-time monitoring of A549 exosomes: early diagnosis of cancer. Anal Chem. 2023;95(13):5738–5746. doi:10.1021/acs.analchem.2c05774
   PubMed Web of Science ®Google Scholar
• Rajaram P, Chandra P, Ticku S, Pallavi BK, Rudresh KB, Mansabdar P. Epidermal growth factor receptor: role in human cancer. Indian J Dent Res. 2017;28(6):687–694. doi:10.4103/ijdr.IJDR_534_16
   PubMedGoogle Scholar
• Zhang H, Deng T, Liu R, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 2017;8(1):15016. doi:10.1038/ncomms15016
   PubMedGoogle Scholar
• Zhou Z, Wu X, Zhan R, et al. Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: a driver of signaling in vivo? Cancer Biol Ther. 2022;23(1):1–13. doi:10.1080/15384047.2022.2133332
   PubMed Web of Science ®Google Scholar
• Huang S-H, Li Y, Zhang J, Rong J, SJCi Y. Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells. Cancer Invest. 2013;31(5):330–335.
   PubMed Web of Science ®Google Scholar
• Song X, Ding Y, Liu G, et al. Cancer cell-derived exosomes induce mitogen-activated protein kinase-dependent monocyte survival by transport of functional receptor tyrosine kinases. J Biol Chem. 2016;291(16):8453–8464. doi:10.1074/jbc.M116.716316
   PubMed Web of Science ®Google Scholar
• Jayasingam SD, Citartan M, Thang TH, Mat Zin AA, Ang KC, Ch’ng ES. Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice. Front Oncol. 2019;9:1512. doi:10.3389/fonc.2019.01512
   PubMed Web of Science ®Google Scholar
• Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022;19(6):402–421. doi:10.1038/s41571-022-00620-6
   PubMed Web of Science ®Google Scholar
• Ruytinx P, Proost P, Van Damme J, Struyf S. Chemokine-induced macrophage polarization in inflammatory conditions. Front Immunol. 2018;9:1930. doi:10.3389/fimmu.2018.01930
   PubMed Web of Science ®Google Scholar
• Wang X, Luo G, Zhang K, et al. Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis tumor-promoting effects of hypoxic exosomal miR-301a. Cancer Res. 2018;78(16):4586–4598. doi:10.1158/0008-5472.CAN-17-3841
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhong X, Nie X, et al. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling. Phytomedicine. 2023;114:154757. doi:10.1016/j.phymed.2023.154757
   PubMed Web of Science ®Google Scholar
• Weinhauser I, Pereira-Martins DA, Almeida LY, et al. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism. Sci Adv. 2023;9(15):eadf8522. doi:10.1126/sciadv.adf8522
   PubMed Web of Science ®Google Scholar
• Li J, Xie Y, Wang X, et al. Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis. Future Oncol. 2019;15(19):2303–2317. doi:10.2217/fon-2018-0669
   PubMed Web of Science ®Google Scholar
• Miyashita T, Tajima H, Shah FA, et al. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models. Ann Surg Oncol. 2014;21(6):2012–2019. doi:10.1245/s10434-014-3537-5
   PubMed Web of Science ®Google Scholar
• Cao W, Peters JH, Nieman D, Sharma M, Watson T, Yu J. Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro. Br J Cancer. 2015;113(5):738–746. doi:10.1038/bjc.2015.292
   PubMed Web of Science ®Google Scholar
• Bhat AA, Lu H, Soutto M, et al. Exposure of Barrett’s and esophageal adenocarcinoma cells to bile acids activates EGFR–STAT3 signaling axis via induction of APE1. Oncogene. 2018;37(46):6011–6024. doi:10.1038/s41388-018-0388-8
   PubMed Web of Science ®Google Scholar
• Shi C, Sun L, Fang R, Zheng S, Yu M, Li Q. Saikosaponin-A exhibits antipancreatic cancer activity by targeting the EGFR/PI3K/Akt pathway. Curr Pharm Biotechnol. 2023;24(4):579–588. doi:10.2174/1389201023666220610113514
   PubMed Web of Science ®Google Scholar
• Lian G, Chen S, Ouyang M, Li F, Chen L, Yang J. Colon cancer cell secretes EGF to promote M2 polarization of TAM through EGFR/PI3K/AKT/mTOR pathway. Technol Cancer Res Treat. 2019;18:1533033819849068. doi:10.1177/1533033819849068
   Web of Science ®Google Scholar
• Manner H. Update Barrett-Ösophagus [Current status in Barrett’s esophagus]. Dtsch Med Wochenschr. 2023;148(3):93–102. German. doi:10.1055/a-1832-3984
   PubMedGoogle Scholar
• Lagergren J. Oesophageal cancer and gastro-oesophageal reflux: what is the relationship? Gut. 2004;53(8):1064–1065. doi:10.1136/gut.2003.038471
   PubMed Web of Science ®Google Scholar
• Jenkins R, Walker J, Roy UB. Plain language summary and patient perspective of the European society for medical oncology expert consensus statements on treating EGFR-positive non-small-cell lung cancer. Future Oncol. 2023;2023:1.
   Google Scholar
• Peng W, Yao C, Pan Q, et al. Novel considerations on EGFR-based therapy as a contributor to cancer cell death in NSCLC. Front Oncol. 2023;13:1120278. doi:10.3389/fonc.2023.1120278
   PubMedGoogle Scholar
• Karan C, Tan E, Sarfraz H, et al. Human epidermal growth factor receptor 2-targeting approaches for colorectal cancer: clinical implications of novel treatments and future therapeutic avenues. JCO Oncol Pract. 2022;18(8):545–554. doi:10.1200/OP.21.00904
   PubMedGoogle Scholar
• Wu Y, Zeng X, Gan Q. A compact surface plasmon resonance biosensor for sensitive detection of exosomal proteins for cancer diagnosis. Methods Mol Biol. 2022;2393:3–14.
   PubMedGoogle Scholar
• Figueroa JM, Skog J, Akers J, et al. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro Oncol. 2017;19(11):1494–1502. doi:10.1093/neuonc/nox085
   PubMed Web of Science ®Google Scholar
• Kharmate G, Hosseini-Beheshti E, Caradec J, Chin MY, Tomlinson Guns ES, Nie D. Epidermal growth factor receptor in prostate cancer derived exosomes. PLoS One. 2016;11(5):e0154967. doi:10.1371/journal.pone.0154967
   PubMed Web of Science ®Google Scholar
• Cao X, Zhong W, Guo S, Zhang Z, Xie C. Low expression of miR-27b in serum exosomes of non-small cell lung cancer facilitates its progression by affecting EGFR. Open Med. 2022;17(1):816–825. doi:10.1515/med-2022-0472
   Web of Science ®Google Scholar
• Tang Y, Hu S, Li T, Qiu X. Tumor cells-derived exosomalcircVCP promoted the progression of colorectal cancer by regulating macrophage M1/M2 polarization. Gene. 2023;870:147413. doi:10.1016/j.gene.2023.147413
   PubMed Web of Science ®Google Scholar
• Xu L, Wang L, Yang R, Li T, Zhu X. Lung adenocarcinoma cell-derived exosomes promote M2 macrophage polarization through transmission of miR-3153 to activate the JNK signaling pathway. Hum Mol Genet. 2023;32(13):2162–2176. doi:10.1093/hmg/ddad052
   PubMed Web of Science ®Google Scholar
• Shou Y, Wang X, Chen C, et al. Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway. Cancer Cell Int. 2022;22(1):153. doi:10.1186/s12935-022-02570-6
   PubMed Web of Science ®Google Scholar
• Wu S, Luo M, To KKW, et al. Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer. Mol Cancer. 2021;20(1):17. doi:10.1186/s12943-021-01307-9
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21(11):799–820. doi:10.1038/s41573-022-00520-5
   PubMed Web of Science ®Google Scholar
• Zhou J, Zheng S, Liu T, et al. IL-1beta from M2 macrophages promotes migration and invasion of ESCC cells enhancing epithelial-mesenchymal transition and activating NF-kappaB signaling pathway. J Cell Biochem. 2018;119(8):7040–7052. doi:10.1002/jcb.26918
   PubMed Web of Science ®Google Scholar
• Chen J, Yao Y, Gong C, et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell. 2011;19(4):541–555. doi:10.1016/j.ccr.2011.02.006
   PubMed Web of Science ®Google Scholar
• Wang W, Wu D, He X, et al. CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis. Cancer Lett. 2019;460:18–28. doi:10.1016/j.canlet.2019.06.009
   PubMed Web of Science ®Google Scholar
• Lin Z, Li W, Zhang H, et al. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-kappaB signaling pathway in hepatocellular carcinoma. Tumour Biol. 2016;37(3):3461–3468. doi:10.1007/s13277-015-4172-x
   PubMedGoogle Scholar
• Wang C, Liang H, Li Y, Tang Z, Zhang Y. Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma. Bioengineered. 2022;13(5):12738–12748. doi:10.1080/21655979.2022.2069383
   PubMed Web of Science ®Google Scholar